Evidence map›Paper›PMID 36033569›Full record

ArticleBioMed research international2022

Viral Dynamic Surveillance in COVID-19 Patients: A Cohort Study.

DeWu Bi, ZhenCheng Chen, ShanQiu Wei, ZhouHua Xie, Ning Zang, LiDa Mo, ZeDuan Liu, YuanLi Wang, LiangLi Cao, FeiJun Zhao and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

DeWu BiAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
ZhenCheng ChenSchool of Life and Environmental Sciences, Guilin University of Electronic Technology, China.
ShanQiu WeiAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
ZhouHua XieAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
Ning ZangGuangxi Medical Research Center, Guangxi Medical University, China.
LiDa MoAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
ZeDuan LiuAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
YuanLi WangSchool of Life and Environmental Sciences, Guilin University of Electronic Technology, China.
LiangLi CaoSchool of Life and Environmental Sciences, Guilin University of Electronic Technology, China.
FeiJun ZhaoSchool of Life and Environmental Sciences, Guilin University of Electronic Technology, China.
YanRong LinAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
YaQin QinAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
XiKe TangAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
HanZhen SuAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
JinAi ZhouGuangxi Medical Research Center, Guangxi Medical University, China.
JuanYing LiangAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
ZhenXu LanAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
Lü LinAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
ShaoYong XiAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
XiaoCheng LuoAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
QiuYing MaAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
XiaoFeng PangAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.
XiaoLu LuoAffiliated Infectious Disease Hospital of Nanning, Guangxi Medical University, China.ORCID https://orcid.org/0000-0001-6676-0617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a potentially fatal pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially those of novel SARS-CoV-2 variants and infection has affected over 700 million people globally. Methods: This retrospective, descriptive study included 118 patients admitted with SARS-CoV-2 infection as confirmed by real-time reverse transcription polymerase chain reaction. Results: The median duration of detectable SARS-CoV-2 infection in patients with high ALT, AST, and PLT/LYMPH, or low CD4+, CD8+, and PLT/MONO was considerably longer. In the risk factor model, multivariate analysis was performed for the estimation of ALT (HR, 0.54; 95% CI, 0.36-0.81), AST (HR, 0.56; 95% CI, 0.34-0.93), CD4+ (HR,0.77; 95% CI, 0.48-1.24), CD8+ (HR,0.64; 95% CI, 0.37-1.11), PLT/LYMPH (HR, 1.16; 95% CI, 0.76-1.77), and PLT/MONO (HR, 0.64; 95% CI, 0.43-0.94). Conclusions: The longer viral RNA duration was associated with a higher International Prognostic Index score (

Indexed as

COVID-19SARS-CoV-2Cohort StudiesHumansRetrospective StudiesRNA, ViralRNA, Viral

Identifiers

PMID36033569
PMCPMC9417765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.